Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03409380
Other study ID # PBRC 2017-027
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 8, 2018
Est. completion date July 8, 2019

Study information

Verified date September 2022
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will assess effects of an acute dose of the amino acid arginine on metabolism in healthy young men.


Description:

A double - blind randomized, crossover design trial examining arginine vs. placebo beverage treatments will be performed. The primary objective is to determine the effects of arginine assessed by standard laboratory assays and metabolomics. To accomplish the objective standardized meals will be provided for 2 days preceding treatment for dietary consistency. Participants will arrive at the center following a 10-12 hr fast. Blood samples will be collected at baseline (fasting), 1.5 hrs, 3.0 hrs, 6.0 hrs, and 24 hrs post treatment. Plasma prolactin, growth hormone, amino acids, glucose, insulin, triacylglycerols, thyroid hormones (TSH, T3, and T4), sex hormone binding globulin (SHBH), testosterone, cortisol, DHEA, and citrulline will be measured. Metabolomics will be measured at 3 time points for each treatment. Peripheral arterial tonometry (PAT) will also be performed at ~2 hrs following treatment to examine endothelial function in response to nitrous oxide release. In addition, psychological status including fatigue will be assessed using a standardized mood questionnaire (POMS).


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 8, 2019
Est. primary completion date July 8, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - BMI 18.5 - 25 kg/m2. - Must be physically active (exercise at least 2 days/week). - Willing to refrain from alcohol and supplements for the duration of the study. - Willing to refrain from supplement ingestion, nuts, watermelon, and cracklins (fatback) for the 2 weeks prior to the initial treatment diet through the duration of the study. Exclusion Criteria: - HIV or AIDS - Uncontrolled CVD/arrhythmia - Type I or type II diabetes - Pregnancy (or breastfeeding) - Diagnosed eating disorder - Non-normal sleeping patterns - Chronic neurological condition - Altered metabolism including growth hormone disorders - Use of nicotine or tobacco products - Heavy caffeine use (= 350 mg caffeine/d) - Whole blood donation within previous eight weeks - Protein supplementation - Protein wasting disease. - Exclusionary medications include diuretics, beta-blockers, weight loss medications or diet pills, anti-inflammatory drugs (corticosteroid/ anabolic steroid/NSAID), antipsychotic medication or other medication that may affect fluid balance, metabolism, or body weight. - Prisoners and adults who are unable to consent will be excluded from the study. - Lastly any other medical, psychiatric, or behavioral factors in the judgement of the Principle Investigator that may interfere with study participation or the ability to follow the protocol.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Arginine Drink
10 g of arginine in a formulated drink
Plain Drink
formulated drink

Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (5)

Lead Sponsor Collaborator
Pennington Biomedical Research Center Corby K. Martin, Frank L. Greenway, Jennifer C. Rood, Robbie A. Beyl

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Growth Hormone Change in GH baseline (fasting), 1.5, 3.0, 6.0, and 24.0 hrs
See also
  Status Clinical Trial Phase
Recruiting NCT02559479 - A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes N/A
Completed NCT04468503 - Comparative Effect of Protein Prescription Strategies on Nitrogen Balance and Upshots in Critically Ill Patients N/A
Completed NCT03561337 - Nutrient Supplementation Influences Mitochondria Adaptation N/A
Recruiting NCT06427018 - Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients
Completed NCT03115775 - CLA and Vitamin D on Protein Turnover N/A
Completed NCT06267235 - Dietary Protein Restriction and Health N/A
Completed NCT03816579 - A Meal-based Comparison of Protein Quality, Complementary Proteins and Muscle Anabolism N/A
Completed NCT04356573 - (KIWI) Speeding up a Slow Protein for Muscle Mass With Hay Kiwifruit N/A
Recruiting NCT04024605 - Bioavailability of Protein and Amino Acids From Oilseeds in Healthy Volunteers N/A
Completed NCT05368311 - Effect of a Protein Intake on Weight Loss of Overweight/Obese Adults N/A
Recruiting NCT05296096 - PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS N/A